[P005] Poster

12:10 PM - 1:00 PM JST(3:10 AM - 4:00 AM UTC)

[P03-309] Prodrug-conjugated tumour-seeking commensals for targeted cancer therapy

Haosheng Shen^1,2,3, Changyu Zhang^4,5, Shengjie Li^1,6, Yuanmei Liang^1,2,3,7, ○Li Ting Lee^1,2,3, Nikhil Aggarwal^1,2,3, Kwok Soon Wun^1,2,3,7, Jing Liu⁸, Saravanan Prabhu Nadarajan^1,2,7, Cheng Weng⁵, Hua Ling^1,2,7,11, Joshua K. Tay^1,2,9, De Yun Wang⁸, Shao Q. Yao⁵, In Young Hwang^1,2,12, Yung Seng Lee^1,2,10, Matthew Wook Chang^1,2,3,7 (1. NUS Synthetic Biology for Clinical and Technological Innovation (SynCTI), National University of Singapore (Singapore), 2. Synthetic Biology Translational Research Programme, Yong Loo Lin School of Medicine, National University of Singapore (Singapore), 3. National Centre for Engineering Biology (NCEB) (Singapore), 4. Ningbo Institute of Dalian University of Technology (China), 5. Department of Chemistry, National University of Singapore (Singapore), 6. Institute of Translational Medicine, Jiangxi Medical College, Nanchang University (China), 7. Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore (Singapore), 8. Department of Otolaryngology, Infectious Diseases Translational Research Program, Yong Loo Lin School of Medicine, National University of Singapore (Singapore), 9. Department of Otolaryngology-Head and Neck Surgery, National University of Singapore (Singapore), 10. Department of Paediatrics, Yong Loo Lin School of Medicine, National University of Singapore (Singapore), 11. Present address: Wilmar International Limited (Singapore), 12. Present address: Food, Chemical and Biotechnology, Singapore Institute of Technology (Singapore))

Keywords:

Prodrug,Bacteria-mediated cancer therapy,Commensals,Lactobacillus,Nasopharyngeal carcinoma

Password required to view

Password required to view

Log in

or